AlphaQuest LLC Sells 8,692 Shares of Teleflex Incorporated $TFX

AlphaQuest LLC decreased its stake in Teleflex Incorporated (NYSE:TFX) by 90.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 893 shares of the medical technology company’s stock after selling 8,692 shares during the quarter. AlphaQuest LLC’s holdings in Teleflex were worth $109,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of TFX. Norges Bank purchased a new position in Teleflex during the second quarter worth $65,826,000. Qube Research & Technologies Ltd lifted its holdings in shares of Teleflex by 100.1% in the 2nd quarter. Qube Research & Technologies Ltd now owns 606,804 shares of the medical technology company’s stock worth $71,821,000 after acquiring an additional 303,521 shares during the last quarter. Wedge Capital Management L L P NC purchased a new position in shares of Teleflex during the 3rd quarter worth about $26,929,000. Boston Partners grew its holdings in Teleflex by 112.5% during the 2nd quarter. Boston Partners now owns 380,933 shares of the medical technology company’s stock valued at $45,085,000 after purchasing an additional 201,652 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in Teleflex by 177.9% during the 2nd quarter. Ameriprise Financial Inc. now owns 305,519 shares of the medical technology company’s stock valued at $36,161,000 after purchasing an additional 195,581 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX opened at $103.78 on Friday. The company has a market capitalization of $4.59 billion, a price-to-earnings ratio of -14.12, a PEG ratio of 1.36 and a beta of 0.92. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $180.58. The business’s fifty day simple moving average is $113.96 and its 200-day simple moving average is $118.93.

Wall Street Analyst Weigh In

Several analysts have issued reports on TFX shares. Needham & Company LLC raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price objective for the company in a research note on Tuesday, January 27th. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Wells Fargo & Company decreased their price target on Teleflex from $139.00 to $116.00 and set an “equal weight” rating for the company in a research note on Thursday, January 29th. Royal Bank Of Canada restated a “sector perform” rating and set a $135.00 price objective on shares of Teleflex in a report on Wednesday, December 17th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Teleflex currently has a consensus rating of “Hold” and an average target price of $139.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.